GECo: Implementation and Effectiveness of COPD Self Management Action Plans in Low and Middle Income Countries (GECo2)
Primary Purpose
Chronic Obstructive Pulmonary Disease
Status
Unknown status
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
COPD Self-Management Plan
Sponsored by
About this trial
This is an interventional health services research trial for Chronic Obstructive Pulmonary Disease focused on measuring COPD, Self-Management, Action Plan, SGRQ, LMIC, COPD Diagnosis
Eligibility Criteria
Inclusion Criteria:
- Male or female participants aged ≥40 years
- Full-time resident in the area (living in area > 6 months)
- Able to perform adequate quality spirometry
- Capable of providing informed consent
- Identified as having COPD grade B-D as per GOLD criteria
Exclusion Criteria:
- Pregnancy (self-reported)
- Currently has active pulmonary TB or is taking medications for pulmonary TB
- Identified as having COPD grade A as per GOLD criteria
Sites / Locations
- Institute of Medicine
- Universidad Peruana Cayetano Heredia
- Makerere University Lung Institute
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Intervention Group
Control Group
Arm Description
Patient education in use of a COPD self-management action plan supported by monthly visits from, and access to, a CHW who has been trained in the use of a COPD self-management action plan.
COPD 'standard' care in local setting - Bhaktapur, Nepal; Lima, Peru; Nakaseke, Uganda
Outcomes
Primary Outcome Measures
Change in SGRQ
Comparison of the change in SGRQ between baseline and 12 months, in the intervention compared to the control arm.
b) Implementation Aim 1: Assess the appropriateness, acceptability and feasibility of using questionnaires and PEF to identify COPD cases from the perspective of local community members, community health workers, local health centre physicians and ministries of health.
Secondary Outcome Measures
Number of Exacerbations
Comparison of the number of COPD exacerbations in 12 months, between the intervention compared to the control arm.
Number of Hospitalisations
Comparison of the number of hospitalisations in 12 months, between the intervention compared to the control arm.
Number of CHW visits
Comparison of the number of CHW visits in 12 months, between the intervention compared to the control arm.
Health-Economics
Assess the cost-effectiveness of a supported COPD Action Plan in terms of health-related costs and health benefits and explore broader cost implications to productivity.
Full Information
NCT ID
NCT03359915
First Posted
November 27, 2017
Last Updated
December 1, 2017
Sponsor
University College, London
Collaborators
Johns Hopkins University, Universidad Peruana Cayetano Heredia, Asociacion Benefica Prisma, Makerere University, University of York, Institute of Medicine, Tribhuvan University, Nepal
1. Study Identification
Unique Protocol Identification Number
NCT03359915
Brief Title
GECo: Implementation and Effectiveness of COPD Self Management Action Plans in Low and Middle Income Countries
Acronym
GECo2
Official Title
Global Excellence in COPD Outcomes: Implementation and Effectiveness of COPD Self-Management Action Plans in Low and Middle Income Countries
Study Type
Interventional
2. Study Status
Record Verification Date
December 2017
Overall Recruitment Status
Unknown status
Study Start Date
December 2017 (Anticipated)
Primary Completion Date
November 2019 (Anticipated)
Study Completion Date
February 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University College, London
Collaborators
Johns Hopkins University, Universidad Peruana Cayetano Heredia, Asociacion Benefica Prisma, Makerere University, University of York, Institute of Medicine, Tribhuvan University, Nepal
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study will randomise people with clinically significant COPD (GOLD Grade B-D) to usual care or provision of a self-management action plan supported by monthly follow-up visits from a community health worker trained in the use of the action plan. The primary outcome will be health-status: a comparison of the change in St. George's Respiratory Questionnaire (SGRQ) between baseline and 12 months in the two groups. We will randomise 240 people from three low- and middle-income countries, namely Nepal, Peru and Uganda. We will also examine the feasibility of implementing our self-management action plan intervention at scale.
Detailed Description
The investigators will determine whether a self-directed COPD Action Plan for the management of COPD exacerbations can be implemented with trained community health workers (CHWs). The investigators hypothesise that COPD action plans with disease-specific education and support from a CHW will lead to improved quality of life and will be locally-appropriate, acceptable, and feasible to implement.
Clinical Aim 1: Assess the clinical effectiveness of CHW-supported COPD Action Plans in LMICs by comparing change in disease-specific quality of life measures (SGRQ) at one year.
Implementation Aim 1: Assess the appropriateness, acceptability, and feasibility of implementing a CHW-supported, self-directed COPD Action Plan for management of COPD exacerbations.
The investigators will also determine whether a CHW-supported, self-directed COPD Action Plan is cost-effective, accounting for implementation realities. We hypothesise that COPD Action Plans are a cost-effective intervention, as measured by the incremental QALY.
Clinical Aim 2: Assess the cost-effectiveness of COPD Action Plans in terms of health-related costs and health benefits and explore broader cost implications to productivity.
Implementation Aim 2: Explore how the value of the COPD Action Plans is affected by both implementation factors that restrict optimal provision ('constraints') and sub-group differences, which have implications for equity.
The final design of our intervention will be informed by formative work prior to commencement of the main study.
Study fieldworkers will enroll and randomise 80 adults aged ≥40 years with GOLD GRADE B-D COPD at each of the following three countries in the catchment areas of existing community census areas in Bhaktapur (Nepal), Lima (Peru), and Nakaseke (Uganda). They will then be randomised via an online system into either a control (usual care) or intervention group.
The intervention arm will receive a specific self-management plan for COPD facilitated by trained CHWs, who will then visit the participants monthly. The control group will receive basic COPD education and be reminded about the sites for their local health care providers. The primary effectiveness outcome for the study will be change in health-status (SGRQ) between baseline and 12 months, across the two groups. We will also examine the cost-effectiveness of self-management for individuals with COPD.
The investigators will also examine the feasibility of implementing our self-management action plan intervention at scale.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Obstructive Pulmonary Disease
Keywords
COPD, Self-Management, Action Plan, SGRQ, LMIC, COPD Diagnosis
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
RCT Phase - Parallel Groups: 240 in total Control arm - 120 participants Intervention Arm - 120 participants
Masking
None (Open Label)
Allocation
Randomized
Enrollment
240 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intervention Group
Arm Type
Experimental
Arm Description
Patient education in use of a COPD self-management action plan supported by monthly visits from, and access to, a CHW who has been trained in the use of a COPD self-management action plan.
Arm Title
Control Group
Arm Type
No Intervention
Arm Description
COPD 'standard' care in local setting - Bhaktapur, Nepal; Lima, Peru; Nakaseke, Uganda
Intervention Type
Behavioral
Intervention Name(s)
COPD Self-Management Plan
Intervention Description
Patient education in use of a COPD self-management action plan supported by monthly visits from, and access to, a CHW who has been trained in the use of a COPD self-management action plan.
Primary Outcome Measure Information:
Title
Change in SGRQ
Description
Comparison of the change in SGRQ between baseline and 12 months, in the intervention compared to the control arm.
b) Implementation Aim 1: Assess the appropriateness, acceptability and feasibility of using questionnaires and PEF to identify COPD cases from the perspective of local community members, community health workers, local health centre physicians and ministries of health.
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Number of Exacerbations
Description
Comparison of the number of COPD exacerbations in 12 months, between the intervention compared to the control arm.
Time Frame
12 months
Title
Number of Hospitalisations
Description
Comparison of the number of hospitalisations in 12 months, between the intervention compared to the control arm.
Time Frame
12 months
Title
Number of CHW visits
Description
Comparison of the number of CHW visits in 12 months, between the intervention compared to the control arm.
Time Frame
12 months
Title
Health-Economics
Description
Assess the cost-effectiveness of a supported COPD Action Plan in terms of health-related costs and health benefits and explore broader cost implications to productivity.
Time Frame
12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Male or female participants aged ≥40 years
Full-time resident in the area (living in area > 6 months)
Able to perform adequate quality spirometry
Capable of providing informed consent
Identified as having COPD grade B-D as per GOLD criteria
Exclusion Criteria:
Pregnancy (self-reported)
Currently has active pulmonary TB or is taking medications for pulmonary TB
Identified as having COPD grade A as per GOLD criteria
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
John R Hurst, FRCP, PhD
Phone
+442074726260
Email
j.hurst@ucl.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
William Checkley, MD, PhD
Email
wcheckl1@jhmi.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John R Hurst, FRCP, PhD
Organizational Affiliation
University College, London
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institute of Medicine
City
Kathmandu
Country
Nepal
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Laxman Shrestha, MD
Email
laxmanshree12@gmail.com
Facility Name
Universidad Peruana Cayetano Heredia
City
Lima
Country
Peru
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jaime Miranda, MD
First Name & Middle Initial & Last Name & Degree
jaime.miranda@upch.pe
Facility Name
Makerere University Lung Institute
City
Makerere
Country
Uganda
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bruce Kirenga, MD
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
30340648
Citation
Siddharthan T, Pollard SL, Quaderi SA, Mirelman AJ, Cardenas MK, Kirenga B, Rykiel NA, Miranda JJ, Shrestha L, Chandyo RK, Cattamanchi A, Michie S, Barber J, Checkley W, Hurst JR; GECo Study Investigators. Effectiveness-implementation of COPD case finding and self-management action plans in low- and middle-income countries: global excellence in COPD outcomes (GECo) study protocol. Trials. 2018 Oct 19;19(1):571. doi: 10.1186/s13063-018-2909-8.
Results Reference
derived
Links:
URL
https://www.globalncd.org/
Description
The Johns Hopkins Center for Global NCD Research and Training Website
URL
https://twitter.com/copdgeco?lang=en
Description
Trial Twitter account - @COPDGECo
Learn more about this trial
GECo: Implementation and Effectiveness of COPD Self Management Action Plans in Low and Middle Income Countries
We'll reach out to this number within 24 hrs